Skip to main content

Table 2 Clinical profile of IDUs, non-IDUs and non-DUs in Coastal Kenya between 2012–2013

From: Nutritional status of people who inject drugs in Coastal Kenya: a cross-sectional study

All participants

Drug Use Status

Variables

 

Non- DUs

Non-IDUs

IDUs

p-value

(N = 752)

(N = 306)

(N = 75)

(N = 371)

 

HIV status

 Negative

455 (61)

194 (63)

48 (64)

213 (57)

0.23

 Positive

297 (39)

112 (37)

27 (36)

158 (43)

 

On ARVs (N = 297 HIV)

201 (68)

88 (79)

17 (63)

96 (61)

0.007

Duration of ARVs (N = 201)

     

 < 6 months

37 (18)

15 (17)

6 (35)

16 (17)

< 0.001

 6 to 11 months

33 (16)

12 (13)

2 (11)

19 (20)

 

 12 to 35 months

68 (33)

14 (15)

2 (11)

52 (54)

 

 ≥ 36 months

69 (33)

51 (55)

9 (47)

9 (9.4)

 

Clinical signs

 Fever

309 (41)

80 (26)

23 (31)

206 (56)

< 0.001

 Vomiting

230 (31)

52 (17)

9 (12)

169 (46)

< 0.001

 Diarrhoea

212 (28)

52 (17)

13 (17)

147 (40)

< 0.001

 Headache

273 (36)

76 (25)

18 (24)

179 (48)

< 0.001

 Cough

346 (46)

109 (36)

36 (48)

201 (54)

< 0.001

Chest examination

 Normal/clear

585 (78)

258 (81)

59 (79)

278 (75)

< 0.001

 Congested

99 (13)

46 (15)

12 (16)

41 (11)

 

 Wheezy

52 (6.9)

0

0

52 (14)

 

 Crepitation

16 (2.1)

12 (3.9)

4 (5.3)

0

 
  1. The medians are compared using Kruskal–Wallis test all other p-values are from chi-square test, IQR; Interquartile range